TABLE 3.

Clinical outcome variables

	n = 954 patients, n (%)
Development of PES	616 (64.6)
PES grade
Mild	168 (17.6)
Moderate	392 (41.1)
Severe	56 (5.9)
mRECIST at 30–90 d
Partial or complete response	478 (50.1)
Stable disease	298 (31.2)
Progressive disease	123 (12.9)
Unknown	55 (5.8)
Liver transplantation	111 (11.6)
Median overall survival (mo)	16.0 (95% CI, 13.9–18.0)

Abbreviation: mRECIST, Modified Response Evaluation Criteria in Solid; PES, postembolization syndrome.